127 related articles for article (PubMed ID: 16647012)
1. [Aspirin resistance in patients taking small dose of aspirin].
Wang CB; Hu DY; Shi XB; Zhu ZY; Zhu JY; Yang JG
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2006 Apr; 18(4):219-23. PubMed ID: 16647012
[TBL] [Abstract][Full Text] [Related]
2. Variability in platelet response to a single daily dose of 150 mg enteric coated aspirin in a high risk population.
Mardikar H; Deo D; Deshpande N; Mardikar M; Ghosh A; Munot K; Steinhubl S; Mukherjee D
J Assoc Physicians India; 2008 May; 56():321-4. PubMed ID: 18700638
[TBL] [Abstract][Full Text] [Related]
3. Increased platelet sensitivity among individuals with aspirin resistance - platelet aggregation to submaximal concentration of arachidonic acid predicts response to antiplatelet therapy.
Guthikonda S; Mangalpally K; Vaduganathan M; Patel R; Delao T; Bergeron AL; Dong JF; Lev EI; Kleiman NS
Thromb Haemost; 2008 Jul; 100(1):83-9. PubMed ID: 18612542
[TBL] [Abstract][Full Text] [Related]
4. Comparison of cationic propyl gallate and adenosine diphosphate for the measurement of aspirin effectivity with optical aggregometry.
Motovska Z; Sujanova Z; Wimmerova S; Ardo J; Skrakova M; Widimsky P
Transl Res; 2007 Oct; 150(4):246-52. PubMed ID: 17900512
[TBL] [Abstract][Full Text] [Related]
5. Low-dose aspirin increases aspirin resistance in patients with coronary artery disease.
Lee PY; Chen WH; Ng W; Cheng X; Kwok JY; Tse HF; Lau CP
Am J Med; 2005 Jul; 118(7):723-7. PubMed ID: 15989905
[TBL] [Abstract][Full Text] [Related]
6. Effect of polymorphism and type II diabetes on aspirin resistance in patients with unstable coronary artery disease.
Gao F; Wang ZX; Men JL; Ren J; Wei MX
Chin Med J (Engl); 2011 Jun; 124(11):1731-4. PubMed ID: 21740787
[TBL] [Abstract][Full Text] [Related]
7. Comparison of increased aspirin dose versus combined aspirin plus clopidogrel therapy in patients with diabetes mellitus and coronary heart disease and impaired antiplatelet response to low-dose aspirin.
Duzenli MA; Ozdemir K; Aygul N; Soylu A; Tokac M
Am J Cardiol; 2008 Aug; 102(4):396-400. PubMed ID: 18678294
[TBL] [Abstract][Full Text] [Related]
8. Hypersensitivity of platelets to adenosine diphosphate in patients with stable cardiovascular disease predicts major adverse events despite antiplatelet therapy.
Christie DJ; Kottke-Marchant K; Gorman RT
Platelets; 2008 Mar; 19(2):104-10. PubMed ID: 17852773
[TBL] [Abstract][Full Text] [Related]
9. Assessment of the antiplatelet effects of low to medium dose aspirin in the early and late phases after ischaemic stroke and TIA.
McCabe DJ; Harrison P; Mackie IJ; Sidhu PS; Lawrie AS; Purdy G; Machin SJ; Brown MM
Platelets; 2005 Aug; 16(5):269-80. PubMed ID: 16011977
[TBL] [Abstract][Full Text] [Related]
10. Aspirin and clopidogrel drug response in patients undergoing percutaneous coronary intervention: the role of dual drug resistance.
Lev EI; Patel RT; Maresh KJ; Guthikonda S; Granada J; DeLao T; Bray PF; Kleiman NS
J Am Coll Cardiol; 2006 Jan; 47(1):27-33. PubMed ID: 16386660
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of dose-related effects of aspirin on platelet function: results from the Aspirin-Induced Platelet Effect (ASPECT) study.
Gurbel PA; Bliden KP; DiChiara J; Newcomer J; Weng W; Neerchal NK; Gesheff T; Chaganti SK; Etherington A; Tantry US
Circulation; 2007 Jun; 115(25):3156-64. PubMed ID: 17562955
[TBL] [Abstract][Full Text] [Related]
12. Relation between atherosclerosis risk factors and aspirin resistance in a primary prevention population.
Faraday N; Becker DM; Yanek LR; Herrera-Galeano JE; Segal JB; Moy TF; Bray PF; Becker LC
Am J Cardiol; 2006 Sep; 98(6):774-9. PubMed ID: 16950183
[TBL] [Abstract][Full Text] [Related]
13. The effectiveness of antiplatelet treatment with aspirin in polymorbid patients.
Paluch Z; Jedlicková V; Skibova J; Adamek T; Alusík S
Int Angiol; 2007 Sep; 26(3):206-12. PubMed ID: 17622200
[TBL] [Abstract][Full Text] [Related]
14. Aspirin resistance in patients with chronic renal failure.
Tanrikulu AM; Ozben B; Koc M; Papila-Topal N; Ozben T; Caymaz O
J Nephrol; 2011; 24(5):636-46. PubMed ID: 21279952
[TBL] [Abstract][Full Text] [Related]
15. [Prevalence of laboratory aspirin resistance in 431 old patients].
Li X; Fan L; Cao J; Wang Q; Liu L; Hu G; Hu Y; Wang Y; Wu R
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2012 Apr; 37(4):338-42. PubMed ID: 22561563
[TBL] [Abstract][Full Text] [Related]
16. Profile and prevalence of aspirin resistance in Indian patients with coronary artery disease.
Sadiq PA; Puri A; Dixit M; Ghatak A; Dwivedi SK; Narain VS; Saran RK; Puri VK
Indian Heart J; 2005; 57(6):658-61. PubMed ID: 16521633
[TBL] [Abstract][Full Text] [Related]
17. The impact of intravenous aspirin administration on platelet aspirin resistance after on-pump coronary artery bypass surgery.
Bach J; Kammerer I; Isgro F; Haubelt H; Vogt A; Saggau W; Hellstern P
Platelets; 2009 May; 20(3):150-7. PubMed ID: 19437331
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and risk factors for aspirin and clopidogrel resistance in patients with coronary artery disease or ischemic cerebrovascular disease.
Kim H; Lee HK; Han K; Jeon HK
Ann Clin Lab Sci; 2009; 39(3):289-94. PubMed ID: 19667414
[TBL] [Abstract][Full Text] [Related]
19. Point-of-care whole blood impedance aggregometry versus classical light transmission aggregometry for detecting aspirin and clopidogrel: the results of a pilot study.
Velik-Salchner C; Maier S; Innerhofer P; Streif W; Klingler A; Kolbitsch C; Fries D
Anesth Analg; 2008 Dec; 107(6):1798-806. PubMed ID: 19020120
[TBL] [Abstract][Full Text] [Related]
20. Factors associated with aspirin resistance in patients premedicated with aspirin and clopidogrel for endovascular neurosurgery.
Reavey-Cantwell JF; Fox WC; Reichwage BD; Fautheree GL; Velat GJ; Whiting JH; Chi YY; Hoh BL
Neurosurgery; 2009 May; 64(5):890-5; discussion 895-6. PubMed ID: 19287328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
